Objective: The main objective of this work is to develop new formulation to enhance the solubility of a highly permeable and a poorly soluble oral drug antihyperglycemic agent, nateglinide by liquisolid compacts.Methods: The liquisolid compact technique is based on dissolving the insoluble drug in propylene glycol, polyethylene glycol 400, tween-80 as non-volatile solvents in which drug is having high solubility and admixture of drug loaded solution with microcrystalline cellulose as carrier, aerosil as coating material, crospovidone as disintegrant, and magnesium stearate as lubricant to convert into acceptably flowing and compressible powder. The prepared liquisolid compacts were evaluated for their flowing properties such as bulk den...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
Nateglinide is an oral antidiabetic agent that should be administered 10-30min before the meal, but ...
The challenge faced by the majority of the pharmaceutical products is the poor solubility of the dru...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
Objective: Nateglinide is a commonly used oral hypoglycemic, biopharmaceutical classification system...
At present 40% of the drugs within the development pipelines, and approximately 60 % of the drugs co...
At present 40% of the drugs within the development pipelines, and approximately 60 % of the drugs co...
At present 40% of the drugs within the development pipelines, and approximately 60 % of the drugs co...
Solubility & dissolution rate enhancement from solid oral dosage form is a key issue for current...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
The poor dissolution rate of water-insoluble drugs is still a substantial problem confronting the ph...
Solubility & dissolution rate enhancement from solid oral dosage form is a key issue for current...
Solubility & dissolution rate enhancement from solid oral dosage form is a key issue for current...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
Nateglinide is an oral antidiabetic agent that should be administered 10-30min before the meal, but ...
The challenge faced by the majority of the pharmaceutical products is the poor solubility of the dru...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
Objective: Nateglinide is a commonly used oral hypoglycemic, biopharmaceutical classification system...
At present 40% of the drugs within the development pipelines, and approximately 60 % of the drugs co...
At present 40% of the drugs within the development pipelines, and approximately 60 % of the drugs co...
At present 40% of the drugs within the development pipelines, and approximately 60 % of the drugs co...
Solubility & dissolution rate enhancement from solid oral dosage form is a key issue for current...
Nateglinide is a non-sulphonylurea insulinotropic oral antidiabetic agent. The main problem in formu...
The poor dissolution rate of water-insoluble drugs is still a substantial problem confronting the ph...
Solubility & dissolution rate enhancement from solid oral dosage form is a key issue for current...
Solubility & dissolution rate enhancement from solid oral dosage form is a key issue for current...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...
This technique is based upon the admixture of drug loaded solutions with appropriate carrier and coa...